“Motor function” and “chronic obstructive pulmonary disease” are emerging concerns in this field, as the abovementioned EA can mitigate motor function defects, one of the neurological impairments induced by stroke, by boosting VEGF levels in peripheral blood serum, cerebral blood flow, and cerebral blood volume [107]. This evidence concerns the gene VEGFA and chronic obstructive pulmonary disease.